European Medicines Agency
Some patients may benefit from a higher dose.
Uncommon side effects (greater than 1 in 1,000, less than 1 in 100 patients) Some people may feel dizzy, especially when getting up from a lying or sitting position, or may experience a fast heart rate.
PHARMACOLOGICAL PROPERTIES
Thrombotic events can be a risk in this population and this possibility should be carefully weighed against the benefit to be derived from the treatment in this patient group.
For Paget’ s disease, only one infusion of Aclasta is given.
Investigations
This is particularly important in those who have reduced or absent awareness of the warning signs of
14.
Remember that 78 units is the maximum dose
It may occur if the insulin dose is too high in relation to the insulin requirement.
F
ADROVANCE not only prevents the loss of bone but actually helps to rebuild bone you may have lost and reduces the risk of bones breaking in the spine and hip.
For a full list of excipients, see section 6.1.
LIST OF EXCIPIENTS
Oral use.
65/ 40 LT-08124 Vilnius Tel. + 370 52 101868
LABELLING
This medicinal product has been authorised under “ Exceptional Circumstances”.
It must not be used in people who are being treated with ciclosporin (used to prevent organ rejection in transplant patients) or with medicines used to prevent blood clots such as warfarin.
Eye disorders optic neuritis
3 pre-filled pens
12.
EU/ 1/ 97/ 046/ 034
79 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
It contains the active substance darbepoetin alfa.
Placental transfer was minimal.
Appropriate dose titration between 500 μ g, 300 μ g, and 150 μ g should be considered.
In the open-label study there was no difference in overall survival between patients treated with recombinant human erythropoietin and controls.
If the rise in haemoglobin is greater than 2 g/ dl (1.25 mmol/ l) in four weeks reduce the dose by approximately 25%, depending on the rate of increase.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS 371 BLISTERED PRE-FILLED SYRINGE LABEL
severe liver injury such as hepatic failure and acute hepatic necrosis that may be fatal
When stopping treatment with ARICLAIM the dose should be gradually reduced over a period of at least one to two weeks in order to reduce the risk of withdrawal reactions (see sections 4.4 and 4.8).
Tél: +33 3 26 50 45 33 Ireland Boehringer Ingelheim Ireland Ltd.
It is supplied in a pre-filled, single-use syringe fitted with a safety system to help prevent needle stick injuries after use.
93.94) 97.98
8.
Rosiglitazone plasma concentrations peak at around 1 h after dosing.
Rosiglitazone should be used with caution in patients with severe renal insufficiency (creatinine clearance < 30 ml/ min).
Interferons, ATC code:
The patient experienced central nervous system symptoms such as restlessness, psychosis, visual hallucinations, proconvulsiveness, somnolence, stupor, and unconsciousness.
6 The secondary measures of efficacy included global assessments of improvement by the examiner, Activities of Daily Living (ADL) subscale scores when OFF and UPDRS motor while ON.
2.
7.
No case of overdose has been reported.
At the end of this period the product should not be put back in the refrigerator, but should be used or discarded.
6.2 Incompatibilities
4 - Gently pinch the skin together around the disinfected injection site (to raise it up a little).
As an increased incidence of thrombotic vascular events (TVEs) has been observed in cancer patients receiving erythropoiesis-stimulating agents (see section 4.8), this risk should be carefully weighed against the benefit to be derived from treatment (with epoetin alfa) particularly in cancer patients with an increased risk of thrombotic vascular events, such as obesity and patients with a prior history of TVEs (e. g. deep vein thrombosis or pulmonary embolism).
Iron supplementation should be started as soon as possible, even several weeks prior to initiating the autologous predeposit, in order to achieve high iron stores prior to starting Binocrit therapy.
Prior exposure to cytotoxic agents Patients who have undergone very extensive prior myelosuppressive therapy may not show sufficient mobilisation of PBPC to achieve the recommended minimum yield (2.0 x 106 CD34+ cells/ kg) or acceleration of platelet recovery to the same degree.
Tel: +48 - 22 345 18 88
500 ml 500 ml
The usual dose is 2-4 mg per kg body weight.
Note:
2.
In volunteers with alcoholic cirrhosis, hepatic MPA glucuronidation processes were relatively unaffected by hepatic parenchymal disease.
Repeated dose toxicity studies in rats identified the liver as the primary target organ for toxicity (increases in transaminases, bile duct hyperplasia, necrosis).
DATE OF REVISION OF THE TEXT
- breathlessness
Read the package leaflet before use
1 1.
EXP {MM/ YYYY}
Do not stop the treatment.
Uncommon:
The maximal blood pressure lowering effect should be reached 6-8 weeks after beginning treatment.
Caution should be exercised when these medicinal products are used concomitantly with entacapone (see also sections 4.3 and 4.4).
15.
There are no interaction data available on the coadministration of indinavir/ ritonavir and amprenavir.
95 Store CRIXIVAN in the original bottle.
3.
In all studies, patient response was better when treatment was started at an early age with good renal function.
If any of the above applies to you, do not take Dafiro and talk to your doctor.
7 h post-ref.
You should check with your child’ s doctor or pharmacist if you are not sure.
Blood and lymphatic system disorders
B CONDITIONS OF THE MARKETING AUTHORISATION
A.
26 6.6 Special precautions for disposal and other handling
The biological efficacy of erythropoietin has been demonstrated after intravenous and subcutaneous administration in various animal models in vivo (rats and dogs).
79 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
3.
BTP is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.
This observation was seen in most but not all studies.
24 Film-Coat:
Aprepitant was discontinued due to adverse reactions in 0.6% of patients treated with the aprepitant regimen compared with 0.4% of patients treated with standard therapy.
Emselex should be administered with caution to patients with autonomic neuropathy, hiatus hernia, clinically significant bladder outflow obstruction, risk for urinary retention, severe constipation or gastrointestinal obstructive disorders, such as pyloric stenosis.
6.
Enbrel has been studied in 2,680 patients with rheumatoid arthritis in double-blind and open-label trials.
Fever
228 PARTICULARS TO APPEAR ON THE OUTER PACKAGING
People using Enbrel should not breast-feed, since it is not known if Enbrel passes into human breast milk.
1 1.
Its use in this indication must be balanced against the reported risk of thromboembolic events.
6.1 List of excipients
STATEMENT OF ACTIVE SUBSTANCE(S)
What is Eucreas?
The efficacy of EVISTA once daily in postmenopausal women aged up to 60 years and with or without a uterus was established over a two-year treatment period.
The main measures of effectiveness were the change in symptoms in two main areas: cognitive (the ability to think, learn and remember) and global (a combination of several areas including general function, cognitive symptoms, behaviour and the ability to carry out everyday activities).
Distribution Rivastigmine is weakly bound to plasma proteins (approximately 40%).
One blister contains 7, 10 or 14 film-coated tablets.
It is recommended that serum transaminases, bilirubin and alkaline phosphatase be checked before the initiation of treatment, every 2 weeks during the first month and monthly thereafter.
in the powder: mannitol and human albumin. in the solvent: sodium chloride, water for injections.
Portugal Serviço local de Atendimento ao utilizador de EXUBERA Tel:
After patient tolerance is established, the infusion rate may be increased gradually with subsequent infusions.
Pharmacokinetic properties of Fendrix or MPL alone has not been studied in humans.
26 • Anovulation A sequential treatment scheme is recommended starting with daily administration of 50 IU Fertavid.
In more severe cases symptoms may include enlargement of the ovaries, accumulation of fluid in the abdomen and/ or chest, weight gain and the occurrence of blood clots in the circulation.
Skin and subcutaneous tissue disorders
POSSIBLE SIDE EFFECTS”).
In case of persistent lack of antibody production, dosage of 0.5 g/ kg/ month is recommended until antibody level returns to normal.
The European Medicines Agency (EMEA) will review any new information on the medicine every year and this leaflet will be updated as necessary.
--
Nervous System Disorders Very Common: - peripheral neuropathy.
Cystoid macular oedema has been reported with GANFORT.
Ελλάδα ΒΙΑΝΕΞ Α.Ε., Τηλ: +30.210.8009111
In a controlled study (ADE10) of imatinib versus chemotherapy induction in 55 newly diagnosed patients aged 55 years and over, imatinib used as single agent induced a significantly higher rate of complete haematological response than chemotherapy (96.3% vs.
România Novartis Pharma Services Inc.
This is predominantly via cytochrome P450 2C8 although other isoforms may be involved to a lesser degree.
Women with a history of tubal disease are at risk of ectopic pregnancy, whether the pregnancy is obtained by spontaneous conception or with fertility treatments.
1.
You should check with your doctor or pharmacist if you are not sure.
Before the vaccine is mixed:
1.
This result is similar to the reported values for factor VIII derived from human plasma.
However, on-treatment HBV DNA response was not maintained off-therapy since all the patients had a rebound in HBV DNA after adefovir dipivoxil and pegylated interferon alpha-2a discontinuation.
Batch
Insulins have no specific overdose definitions because serum glucose concentrations are a result of complex interactions between insulin levels, glucose availability and other metabolic processes.
4.
205 C.
If you accidentally push the injection button while setting your dose, you must prime the pen again before injecting your dose.
N=110 n (%)
0.8 (0.4-1.2) 0.5 (0-1.0)
EU/ 1/ 96/ 027/ 005
It is assumed that the pharmacokinetics of metformin absorption are non-linear.
Correction of this condition prior to administration of Imprida or close medical supervision at the start of treatment is recommended.
5.
METHOD AND ROUTE(S) OF ADMINISTRATION
For a full list of excipients, see Section 6.1.
Batch:
EU/ 1/ 06/ 368/ 052
Continuous rotation of the injection site within the given injection area may help to reduce or prevent these reactions.
Continuous rotation of the injection site within the given injection area may help to reduce or prevent these reactions.
The acute toxicity was studied following subcutaneous administration in rats.
Eyes disorders
Medicinal product subject to medical prescription.
You must use the pen as described in these Instructions for Use.
In each case, it may be necessary to adjust your insulin dosage to avoid blood sugar levels that are either too low or too high.
Hypoglycaemia is also more likely to occur if:
Insulin Human Winthrop Comb 25 is supplied in cartridge containing 3 ml suspension (300 IU).
You should know these factors so that you are able to react correctly to changes in your blood sugar level and to prevent it from becoming too high or too low.
By controlling the level of blood glucose, the symptoms and complications of diabetes are reduced.
PHARMACEUTICAL FORM
2.
Alternatively, it may emerge gradually over a period of several weeks.
Insuman Comb 50 may be mixed with all Sanofi-Aventis human insulins, but NOT with those designed specifically for use in insulin pumps.
MARKETING AUTHORISATION NUMBER(S)
- you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly,
Tel: +386 1 560 48 00
- Do not take a double dose to make up for a forgotten dose.
Using Insuman Comb 25 with food and drink
It may harm them, even if their
example through incorrect storage,
Sími: + 354 530 3700
Chronic Hepatitis C:
Neoplasms benign, malignant and unspecified (including cysts and polyps)
IntronA may be administered using either glass or plastic disposable injection syringes.
Due to the lack of data in children with severe
1.
Industriepark 30 B-2220 Heist-op-den-Berg Belgium
Like all medicines, IntronA can cause side effects, although not everybody gets them.
Due to different pharmacodynamic and pharmacokinetic profiles among antipsychotic medicinal products, supervision by a clinician is needed when switching to another antipsychotic product is considered medically appropriate.
7 TABLET OPA-ALU-PVC/ ALU BLISTER
These may include loss of fat from legs, arms and face, increased fat in the abdomen (belly) and other internal organs, breast enlargement and fatty lumps on the back of the neck (’buffalo hump’).
Lithium: reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Keep out of the reach and sight of children.
The combination of hydrochlorothiazide and irbesartan produces dose-related additive reductions in blood pressure across their therapeutic dose ranges.
General disorders and administration site conditions:
6.
Hepatitis, abnormal liver function
90 If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
2 Hepatic impairment No dosage adjustment is required for patients with mild to moderate hepatic impairment.
Not all pack sizes may be marketed in your country.
Week 24†
It is not known whether this medicinal product is excreted in human milk.
Your doctor should monitor you if you are
Less than 2% of the dose is excreted in the urine as unchanged irbesartan.
However, there was no difference in the half-life and accumulation of irbesartan.
Marketing Authorisation Holder BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH - United Kingdom
A significant correlation between saliva and plasma concentrations has been shown in adults and children (ratio of saliva/ plasma concentrations ranged from 1 to 1.7 for oral tablet formulation and after 4 hours post-dose for oral solution formulation).
Bottle of 300 ml.
MARKETING AUTHORISATION HOLDER
BATCH NUMBER
2.
In clinical trials with KOGENATE Bayer, this happened in 14% of previously untreated patients and in 17% of children who had been treated for less than five days in the past.
77 MedDRA System Organ Class Blood and lymphatic sytem disorders Gastrointestinal disorders
Tél/ Tel: +32-(0)2-535 63 11 България Байер България ЕООД Tел. + 359 02 81 401 01 Č eská republika Bayer Schering Pharma Schering s. r. o.
4.3 Contraindications
Unchanged insulin glargine and degradation products are also present in the plasma.
- tell you when you may need to inject a higher or lower dose of Lantus.
PHARMACEUTICAL FORM AND CONTENTS
Take a Levitra tablet about 25 to 60 minutes before sexual activity.
Liprolog Basal has a prolonged absorption profile, achieving a maximum insulin concentration approximately 6 hours after dosing.
READ ENCLOSED PACKAGE LEAFLET
Please keep this possible problem in mind in all situations where you might put yourself and others at risk (e.g. driving a car or operating machinery).
- if you are allergic (hypersensitive) to insulin lispro or any of the other ingredients of Liprolog
ANCHOR LUCENTIS 0.5 mg (n=140) Verteporfin PDT (n=143)
Take as much time as you need to inject all the solution.
The maximum dosage of 600 mg per day may be achieved after an additional week.
20 For any information about this medicine, please contact the Marketing Authorisation Holder.
MabThera maintenance treatment consisted of a single infusion of MabThera at 375 mg/ m2 body surface area given every 3 months until disease progression or for a maximum period of two years.
Intravitreal use.
Muscoloskeletal and connective tissue disorders
As with other vasodilators, special caution is indicated in patients suffering from aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy.
6.4 Special precautions for storage
6.3 Shelf life
HOW TO TAKE MIRAPEXIN
Roche Registration Limited 6 Falcon Way Shire Park Welwyn Garden City AL7 1TW United Kingdom
To ensure effective erythropoiesis, iron status has to be evaluated for all patients prior to and during treatment.
EXP
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Mixtard 10 Penfill
You can dial doses from 2 to 78 units in increments of 2 units.
However, M-M-RVAXPRO may not always be able to prevent measles developing in these cases.
Neutropenia persisted for a median of 13 days.
5.
MARKETING AUTHORISATION NUMBER(S)
If you forget to take Neoclarityn oral lyophilisate If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule.
NeoRecormon is administered twice weekly over 4 weeks.
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, and toxicity to reproduction.
15.
4.
General Disorders and Administration Site Conditions
The initial every other week dose of Nespo (μ g/ every other week) can be determined by dividing the total cumulative dose of r-HuEPO administered over a two-week period by 200.
A systematic review has also been performed involving more than 9000 cancer patients participating in 57 clinical trials.
approximately 25% lower than the previous dose after haemoglobin levels fall to 12 g/ dl (7.5 mmol/ l) ed
In this study, mean (SD) terminal half-life was 74 (SD 27) hours.
th Medicinal product subject to medical prescription.
10.
Neulasta is essentially sodium- free.
100 patches
Self adhesive matrix layer:
Avoid sunlight and solarium exposure on areas of skin showing any kind of skin reaction caused by Neupro.
Caution is needed when it is taken with other medicines.
Adult Use
For a full list of excipients, see section 6.1.
1 ml contains 100 U (3.5 mg) of insulin aspart.
8 Vials in use or carried as a spare:
Like all medicines, NovoRapid can cause side effects, although not everybody gets them.
Mean clearance was approximately 50% higher in paediatric patients relative to adults (78 versus 53 ml/ kg. h), whereas the mean terminal half life was determined to 2.3 hours in both groups.
Absorption
Haematologic toxicity:
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
CONDITIONS OF THE MARKETING AUTHORISATION
Dogs tolerated single oral doses up to 100 mg/ kg without mortality.
OTHER
Omnitrope 5 mg/ ml powder and solvent for solution for injection Somatropin Subcutaneous use
Cardiac
Out of these, approximately 900 were in more advanced stages, received concomitant levodopa therapy, and suffered from motor complications.
GENERAL CLASSIFICATION FOR SUPPLY
Detailed information on this product is available on the European Medicines Agency (EMEA) web site http: / /www. emea. europa. eu
7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
OTHER SPECIAL WARNING(S), IF NECESSARY
PHARMACOLOGICAL PROPERTIES
19 Your doctor will tell you how long your treatment will last.
8.
Aplastic anemia
20 June 2002/ 20 June 2007
2 Combination therapy PegIntron 1.5 micrograms/ kg/ week in combination with ribavirin capsules.
Rare:
Plasma HCV-RNA is measured with a research-based quantitative polymerase chain reaction assay by a central laboratory * Intent to treat population includes 7 patients for whom at least 12 weeks of prior therapy could not be confirmed.
Severe CNS effects, particularly depression, suicidal ideation and attempted suicide have been observed in some patients during PegIntron therapy, and even after treatment discontinuation mainly during the 6-month follow-up period.
100% (42/42) 100% (20/20)
Check with your doctor immediately if any of the following side effects occur: chest pain; changes in the way your heart beats; breathing problems (including shortness of breath), confusion; feeling depressed, wanting to harm yourself, hallucinations, numbness or tingling feeling; dizziness, convulsion ("fit"); trouble sleeping, thinking or concentrating; difficulty remaining alert, severe stomach pain or cramps;
Very rarely, PegIntron alone or in combination with ribavirin may cause aplastic anaemia.
Both residual and additional segments may be treated in the same light session(s) if the total length of the segments treated with the balloon/ diffuser combination is not greater than 7 cm.
The effect of co- administration with posaconazole on plasma levels of CYP3A4 substrates may also be variable within a patient, unless posaconazole is administered in a strictly standardised way with food, given the large food effect on posaconazole exposure (see section 5.2).
Coadministration of antipsychotic medicinal products with pramipexole should be avoided (see section 4.5).
22 Very rare:
As with other vaccines, the administration of Prevenar should be postponed in subjects suffering from acute moderate or severe febrile illness.
* dose used in drug-interaction study.
- pimozide or sertindole (to treat psychiatric conditions)
Dual blockade of the renin-angiotensin-aldosterone system (e. g. by adding an ACE- inhibitor to an angiotensin II receptor antagonist) is therefore not recommended in patients with already controlled blood pressure and should be limited to individually defined cases with close monitoring of renal function.
The inhibitory effect is maintained over 24 hours and still measurable up to 48 hours.
PROCOMVAX will not prevent hepatitis caused by other viruses known to infect the liver.
Rivastigmine was not mutagenic in a standard battery of in vitro and in vivo tests, except in a chromosomal aberration test in human peripheral lymphocytes at a dose 104 times the maximum clinical exposure.
OTHER
Merck Sharp & Dohme OÜ, Tel: +372.613.9750 Ελλάδα:
79 Marketing Authorisation Holder and Manufacturer
Human data demonstrate that, after systemic administration, tacrolimus is excreted into breast milk.
Other common
The starting dose is maintained for at least seven days.
OTHER SPECIAL WARNING(S), IF NECESSARY
• if you have a tumour of the ovary, breast, uterus, testis, pituitary gland or hypothalamus • if you are allergic (hypersensitive) to follitropin beta or any of the other ingredients of Puregon • if you have heavy or irregular vaginal bleeding where the cause is not known • if you suffer from primary ovarian failure • if you have ovarian cysts or enlarged ovaries not caused by polycystic ovarian disease (PCOD) • if you have malformations of the sexual organs which make a normal pregnancy impossible • if you have fibroids in the uterus which make a normal pregnancy impossible • if you suffer from primary testicular failure.
colloidal anhydrous silica and sodium benzoate (E211).
Fondaparinux does not M
3.
General supportive measures should be initiated in all cases of overdose.
Powder and solvent for solution for injection
Therefore, concomitant use of aliskiren and P-gp potent inhibitors is contraindicated (see section 4.3).
Rasilez HCT 150 mg/ 25 mg
EU/ 0/ 00/ 000/ 000
Oral use Read the package leaflet before use.
EXPIRY DATE
Factor VIII level required (% or IU/ dl)
- if you are pregnant or breast-feeding.
30 ANNEX II
1 x 1 ml concentrate for solution for infusion 4 x 1 ml concentrate for solution for infusion 10 x 1 ml concentrate for solution for infusion
Blood pressure should be closely monitored and adequately controlled in all epoetin treatment naïve as well as pre-treated patients before, at initiation of, and during treatment with Retacrit.
For intravenous or subcutaneous use.
Patients should not donate blood or semen during therapy or for 1 week following discontinuation of lenalidomide.
The clinical impact of such findings has not been demonstrated in the absence of specific studies on cardiovascular risk.
↓ 0.62
Tel: + 351 21 440 70 00
- allergic reactions
Doses below 1025 mg of this medicinal product contain less than 1 mmol sodium (23 mg), i.e. essentially ‘sodium free’.
They vary in that they may carry different antigens.
11.7 ± 6.7
Medicinal product subject to medical prescription
Route of Administration Oral use
Therefore, in patients with renal anaemia the medicinal product has to be administered intravenously.
152 PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON
10 single doses, 0.5 ml pre-filled syringes with 1 needle each.
< 0.001
12 Renal impairment No dosage adjustment is required in patients with mild to moderate renal insufficiency, because Sonata pharmacokinetics is not altered in such patients.
However, if it is almost time for your next dose you should simply take the next tablet at the usual time.
Distribution:
- A previous history of Neuroleptic Malignant Syndrome (NMS) and/ or non-traumatic
Although safety was not compromised in this population dose adjustment may be required in view of low Cmax.
With efavirenz, an increase of the lopinavir/ ritonavir soft capsule or oral solution doses by 33% should be considered
For this reason, efavirenz oral solution should not be given to children less than 3 years of age.
Patients with a prior history of psychiatric disorders appear to be at greater risk of these serious psychiatric adverse reactions.
1.
When treatment with voriconazole is stopped, the initial dosage of efavirenz should be restored (see section 4.5).
Capsule shell Gelatine Sodium laurilsulfate Yellow iron oxide (E172) Silicon dioxide (E551)
2.
Flatulence Oral pain Constipation Glossodynia Dry mouth Gastro-oesophageal reflux disease
For children undergoing cardiac bypass, it is recommended that a 15 mg/ kg of body weight injection of palivizumab be administered as soon as stable after surgery to ensure adequate palivizumab serum levels.
The prevention study did not contain a placebo arm, i. e. was an uncontrolled study. b Unit dose = weight-based dosing (see section 4.2). c Patients experienced ear ache and ear pain.
Slovenská republika Roche Slovensko, s.r.o.
- localised swelling (oedema)
Tel: +386 - 1 360 26 00
The pharmacokinetics of tolcapone have not been investigated in patients with renal impairment.
The concentrate is a clear viscous, yellow to brown-yellow solution.
The concomitant use of aliskiren with ciclosporin, a highly potent P-gp inhibitor, and other potent P- gp inhibitors (quinidine, verapamil), is contraindicated (see section 4.5).
EU/ 1/ 04/ 282/ 001
Herpes simplex, herpes zoster, influenza–like symptoms
5.
Bucureşti-Ploieşti, nr.
Batch
8 Table 2:
Breast-feeding should only be resumed following advice from your doctor.
CLINICAL PARTICULARS
2.
Laropiprant and its acyl glucuronide conjugate are the major circulating components in human plasma.
MARKETING AUTHORISATION NUMBER(S)
In clinical trials an increased risk of serious infections in patients receiving Trudexa has been shown, and reports from the post-marketing setting support this finding.
Therapy continued beyond 12 weeks did not result in significantly more responses (see section 4.2).
It is important to tell your doctor if you have had or have a serious heart condition (see “ Take special care with Trudexa”).
4.
10.
5.
6.5 Nature and contents of container
134 (39)
Food decreases the extent and slightly delays the absorption of metformin.
P1 Program 1:
If rifabutin coadministration with voriconazole is justified then the maintenance dose of voriconazole may be increased to 5 mg/ kg intravenously twice daily or from 200 mg to 350 mg orally, twice daily (100 mg to 200 mg orally, twice daily in patients less than 40 kg) (see section 4.2).
Plasma concentrations of this metabolite are approximately 40% of those seen for sildenafil.
Vimpat treatment has been associated with dizziness or blurred vision.
If you are breast-feeding, please inform your doctor immediately; he/she will decide if you should take Vimpat.
What VIRACEPT looks like and contents of the pack:
3%
The aetiology has not been defined.
6 months after the end of treatment.
NAME OF THE MEDICINAL PRODUCT
lp
Then press the push button down fully (see Diagram P). dic Me
The data suggest that no alteration in ViraferonPeg dosage is necessary based on advancing age.
Other:
28.6 (134/468) 23.3, 34.0
ViraferonPeg should be used with caution in patients with moderate to severe renal impairment.
In combination therapy with ribavirin, ribavirin can be very damaging to an unborn baby, thus both female and male patients must take special precautions in their sexual activity if there is any chance for pregnancy to occur:
Look carefully at the reconstituted solution prior to administration.
For smaller children an oral suspension liquid form is available.
Visudyne therapy should be considered carefully in patients with moderate hepatic impairment or biliary obstruction since no experience has been gained in these patients.
Bayer HealthCare AG, D-51368 Leverkusen, Germany.
Shire will conduct a pharmacokinetic study in young and elderly patients with ET.
Marketing Authorisation Holder:
Data from a placebo-controlled clinical trial which was stopped for futility after 477 patients 0 to 17 years-old had received the study treatment did not establish efficacy of Xigris in
Treatment with Xolair in this open label study led to a 61% reduction in clinically significant asthma exacerbation rate compared to current asthma therapy alone.
Do not use if solid particles are present.
- If you have liver disease.
This leaflet was last approved in {MM/ YYYY}
A lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other CYP1A2 inhibitors, such as ciprofloxacin.
BATCH NUMBER
Any unused product or waste material should be disposed of in accordance with local requirements.
3.3 3.3
Metabolic and nutrition disorders:
It may harm them, even if their symptoms are the same as yours.
Symptoms usually appeared within the first six weeks (median time to onset 11 days) of initiation of treatment with abacavir, although these reactions may occur at any time during therapy.
Adults Based on the patient’s current dose of metformin, Zomarist may be initiated at either the 50 mg/850 mg or 50 mg/1000 mg tablet strength twice daily, one tablet in the morning and the other in the evening.
Zometa 4 mg/ 5 ml concentrate for solution for infusion Zoledronic acid
There are no studies in pregnant women.
Antipsychotic supplementation is not required at the initiation of ZYPADHERA treatment (see section 4.2).
Clinically significant weight gain (≥ 7%) appears to occur more frequently in the adolescent population compared to adults with comparable exposures.
Thrombocytopenia
Date of CPMP final opinion
The EMEA participated in a range of activities with the World Health Organisation (WHO) in 2001 relating to medicines for both human and veterinary use.
Released for consultation November 2001
Note for Guidance on Clinical investigation of medicinal products in the treatment of diabetes mellitus
EMEA representatives also attended meetings of the informal European Parliament Intergroup on pharmaceuticals, chaired by Professor Umberto Scapagnini, MEP.
52
Page 3
This covers the time from pre-submission discussion through to authorisation and the production of the European public assessment report (EPAR).
He was elected Chairperson of the Committee for Orphan Medicinal Products in May 2000.
3.1
It also covers the costs of organising meetings, fees and travel expenses of interpreters or conference operators, translation costs where relevant, the costs of Agency staff attending such meetings, interim and other staff to assist in the execution of the programme, IT- related expenditure and other costs in relation to these activities.
Very common Gastrointestinal disorders
6.5 Nature and contents of container
Not all pack sizes may be marketed.
23 Distribution
Moxifloxacin should not be used concurrently with other drugs that prolong the QT interval (see also section 4.5).
Monitoring is especially important in elderly patients on concomitant treatment with cardiac glycosides or diuretics (see section 4.5) and in patients with a high tendency to calculus formation.
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
MARKETING AUTHORISATION NUMBER(S)
Luxembourg
Dose adjustments for patients with impaired renal function The CHMP reviewed the Applicant/ MAH’ s initial proposal for dose adjustment in case of renal impairment and considered it incomplete and poorly substantiated.
Typhoid fever Intra-abdominal infections due to Gram-negative bacteria
3.
If clinical improvement is not achieved after 3 days of treatment, the therapy should be reconsidered.
serum sickness) (see Section 2:
- eyesight problems
4.4 Special warnings and special precautions for use Hypotension ACE inhibitors may cause a fall in blood pressure.
13.
6.
The mean duration of follow-up was nearly two years.
Wyeth Medica Ireland Little Connell – Newbridge, Co.
41 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
film-coated tablets
Patients with mild hepatic dysfunction (Child-Pugh score 5-6) administered etoricoxib 60 mg once daily had an approximately 16% higher mean AUC as compared to healthy subjects given the same regimen.
This is also the case with used transdermal patches.
EXPIRY DATE
Important information about some of the ingredients of X This medicinal product contains less than 1 mmol sodium (23 mg) per dose (based on the average amount given to a 70 kg person), i. e. essentially ‘ sodium-free’.
16/16
GlaxoSmithKline AB Box 516 169 29 Solna Sweden
21 February 2006 EMEA/ CHMP/ 373083/ 2005
1103 Budapest, Gyömrő i út 19-21.
Loratadin Acis 10 mg
Section 4.6.
Oral use
6.6 Instructions for use and handling< and disposal > No special requirements.
Oral Use
Oral use
Bulgaria
Torrex Chiesi Pharma Gmbh Gonzagagasse 16/ 16 1010 Vienna Austria
Nycomed Ab Box 27264 Se-102 53 Stockholm Sweden
Several cases of accidental over dosage have been reported; symptoms have included tremor, headache, nausea and vomiting, infections, urticaria, lethargy, increased blood urea nitrogen and elevated serum creatinine concentrations, and increase in alanine aminotransferase levels.
EMEA/ CHMP/ 46089/ 2006/ EN< [To be completed nationally] >
21 – Care should be taken in patients with micturition disturbances like prostate hypertrophy and in patients with acute narrow-angle glaucoma and increased intra-ocular pressure (although there is little chance of problems with Remeron because of its very weak anticholinergic activity). – Akathisia/ psychomotor restlessness:
In these patients consideration should be given to using a different type of dialysis membrane or a different class of antihypertensive agent.
Risperidonum
Saunderton High Wycombe Buckinghamshire HP14 4HJ United Kingdom
Latvia
Patients should hold the inhaler upright between fingers and thumb with their thumb on the base, below the mouthpiece.
The SINGULAIR 4 mg granules formulation is not recommended below 6 months of age.
Section 4.5 of the draft Summary of Product Characteristics for terfenadine containing medicinal products should be amended as set out in Annex I.
1.25 mg 2.5 mg 5 mg 10 mg
Route of administration
The severity of vigabatrin attributed VFD could be determined for 92 patients.
10
As a result of these changes the ratios of total- to HDL-C and LDL- to HDL-C are reduced.
please tell your doctor or pharmacist.
Since 1998 post-marketing studies have been performed as well as regular monitoring of adverse effects by FAQ system.
Oral solution
Spot-on solution Dogs
The major metabolite of tylvalosin is 3-acetyltylosin (3-AT), which is also microbiologically active.
Teléfono: +34 91 4909900
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Skiereszewo, ul.
Information on the prescription status of this product may be found on the label of the carton.
Equilis StrepE is only for use in healthy horses that are at risk of S. equi infection due to contact with horses from areas where the bacterium is known to be present.
Primary vaccination of cats 9 weeks and older: two doses at an interval of 3 to 4 weeks.
2.
Intramuscular use
AB Science S. A.
Active substance(s):
2.
Any person intending to import, sell, supply and/ or use Nobilis Influenza H5N6 must consult the relevant Member State’ s competent authority on the current vaccination policies prior to the import, sale, supply and/ or use.
Cardboard box containing 1 vial of lyophilisate and 1 vial of solvent.
4.
If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
1 aluminium foil/ PVC blister
CEVA
(mg/kg bw) 12 - 60 12 - 24 12 - 19.2
WITHDRAWAL PERIOD
In the presence of high levels of maternally derived antibodies, the primary vaccination course should be delayed until 12 weeks of age.
VIRBAC S. A.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product.
The active substance stimulates active immunity against Aujeszky’ s Disease in pigs.
- a reduction of mortality:
ADVICE ON CORRECT ADMINISTRATION
